Who these treatments are for GLP-1 medications are approved for adults with: Obesity (BMI of 30 kg/m or higher) A BMI of 27 kg/m or higher with at least one weight-related condition such as high blood pressure Among individuals with a BMI of 27 kg/m or more, additional benefits have been found
You will protect yourself from, you know, Lipitor and, and other cholesterol meds that are literally just an issue manifesting from a thyroid condition
About 700 of them took GLP-1 receptor agonists (e.g., semaglutide, dulaglutide, exenatide)
6 This process helps protect your cells from damage
Swiss Blue 6
Potential benefit - A patient whose biomarkers suggest rapid metabolism of GLP-1 drugs might be offered a longer-acting formulation, while someone with strong GIP responsiveness could start on a dual-agonist right away, avoiding months of trial-and-error